Diana Roettger, PhD, and Olga Kubassova, PhD[email protected]MRIAdvanced imaging offers insight into targeted therapiesMajor breakthroughs are emerging in the development of targeted therapies that use the body's own immune system to attack cancer cells. But traditional methods of measuring the success of drug candidates are slow and expensive. Could advanced imaging help? Diana Roettger, PhD, and Olga Kubassova, PhD, of the Image Analysis Group offer a perspective.February 5, 2019Page 1 of 1Top StoriesCTUsing GPT‑4o with CT exams helps diagnose ovarian cancer earlierEarly detection of ovarian cancer is a persistent challenge, with more than half still diagnosed at metastatic stages.Womens ImagingSurvey: Nearly 4 out of 5 practices short on breast imagersRadiation Oncology/TherapyPooled evidence: Lu-177 PSMA-617 vs. established therapies in mCRPCMRICardiac MRI-based ML model predicts MACE risk for STEMI patientsSponsor ContentHow Agentic AI Is Transforming Radiology Ops